Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Dew

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2011
Methyl selenocysteine: single-dose pharmacokinetics in menJames R Marshall, Clement Ip, Karen Romano, et al.
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2011
Methyl selenocysteine: single-dose pharmacokinetics in menJames R Marshall, Clement Ip, Karen Romano, et al.
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 2